期刊文献+

缺氧对肺腺癌细胞甲酰肽受体及其侵袭力的影响

Effects of Hypoxia on FPR1 Expression and Invasiveness of A549 Cells
下载PDF
导出
摘要 目的探讨缺氧对人肺腺癌细胞甲酰肽受体1(formyl peptide receptor 1,FPR1)表达及其对肿瘤细胞侵袭力的影响。方法将人肺腺癌细胞株A549暴露于常氧(21%O2)和缺氧(1%O2)条件下培养4、12、24 h,应用RT-PCR检测FPR1 mRNA水平,采用Western blot检测培养上清FPR1激动剂脂联素1(Annexin 1,ANX1)的表达量。用趋化实验检测缺氧对A549细胞FPR1活性的影响。用FPR1外源性激动剂fMLP(formyl-met-leu-phe)刺激细胞后,用RT-PCR观察FPR1 mRNA的变化;同时采用体外侵袭实验检测其对肿瘤细胞侵袭能力的影响。结果与常氧组相比,缺氧上调A549细胞FPR1表达的同时也增加A549细胞FPR1的趋化活性,增加FPR1内源性激动剂Annexin 1的产生。fMLP刺激细胞后,FPR1 mRNA表达水平上调。体外侵袭实验结果表明,缺氧细胞侵袭能力显著增强,加入FPR1拮抗剂Boc2后,缺氧细胞侵袭能力减弱(P<0.05)。结论缺氧增加肺腺癌细胞FPR1激动剂产生与FPR1基因表达。FPR1激动剂的产生在缺氧诱导的FPR1基因表达上调中发挥了作用。缺氧引起A549细胞侵袭力增强与FPR1有关。 Objective To evaluate the effects of hypoxia on the expression of formyl peptide receptor 1(FPR1) and the invasiveness of lung adenocarcinoma cell lines A549.Methods A549 cells were exposed to either normoxia(21%O2) or hypoxia(1%O2) condition for 4,12 and 24 h.The expressions of FPR1 mRNA levels were measured by RT-PCR.The expressions of Annexin 1 protein and FPR1 activity were investigated by Western blot and chemotaxis assay.Cells invasiveness was assayed by matrigel transwell.Results Compared with normoxia group,the FPR1 mRNA in hypoxia group increased;moreover,Annexin 1 in culture medium supernatants of A549 cells also functional increased.Treatment of FPR1 agonist fMLP increased the mRNA level of FPR1 in A549 cells.Hypoxia significantly increased the number of A549 cells invaded across the transwell matrixgel,and FPR specific antagonist Boc2 attenuated the hypoxia-induced invasiveness of A549 cells.Conclusion The results suggest that hypoxia plays an important role in the augmentation of the FPR1 expression and its agonist production,which were involved in the invasiveness of lung cancer cells.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第6期654-657,共4页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金资助项目(30973446) 重庆市自然科学基金资助项目(CSTC2009BB5023) 教育部重点实验室开放课题
关键词 缺氧 肺腺癌 甲酰肽受体1 侵袭 Hypoxia Lung Adenocarcinoma Formyl peptide receptor 1 Invasiveness
  • 相关文献

参考文献9

  • 1Leo C, Giaccia AJ, Denko NC. The hypoxic tumor microenvi- ronment and gene expression[J]. Semin Radiat Oncol,2004,14 (3) :207-14.
  • 2Ye RD, Boulay F, WANG JM, et al. International Union of Basic and Clinical Pharmacology. LXXⅢ. Nomenclature for the formyl peptide reeeptor(FPR) family[J]. Pharmacol Rev, 2009,61 (2): 119-61.
  • 3Zhou Y, Bian X, Le Y, et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas[J]. J Natl Canc- er Inst,2005,97(ll) :823-35.
  • 4胡振红,黄缄,李清泉,杨炯,钟立厚,曾群丽.缺氧对人肺腺癌细胞浸润迁移能力及MMP-2、TIMP-2表达的影响[J].中国肺癌杂志,2005,8(4):270-273. 被引量:6
  • 5Otrock ZK, Hatoum HA, Ahmad AH, et al. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives [J]. Crit Rev Oncol Hematol, 2009, 70 (2) : 93-102.
  • 6Wang JM, Deng X, Gong W, et al. Chemokines and their role in tumor growth and metastasis[J]. J Immunol Methods, 1998, 220(1-2) : 1-17.
  • 7Singh R, Lillard JW Jr, Singh S. Chemokines: key players in cancer progression and metastasis[J]. Front Biosci(Sehoi Ed) 2011,3: 1569-82.
  • 8程希远,王明伟.甲酰肽受体研究进展[J].生命科学,2004,16(3):154-159. 被引量:8
  • 9Huang J,Chen K, Chen J, et aL The G-protein-coupled formylpep- tide receptor FPR confers a more invasive phenotype on human glioblastoma cells[J]. Br J Cancer,2010,102(6) : 1052-60.

二级参考文献46

  • 1Deng X Y, Ueda H, Su S B, et al. A synthetic peptide derived from human immunodeficiency virus type 1 gp120downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled rec
  • 2Bylund J, Karlsson A, Boulay F, et al. Lipopolysaccharideinduced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect Immun, 2002,70(6): 2908~2914
  • 3Chen X, Mellon R D, Yang L, et al. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. Biochem Pharmacol, 2002,63:533~541
  • 4Mills J S, Miettinen H M, Cummings D, et al. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phc and Met-Met-Trp-Leu-Leu. J Biol Chem, 2000, 275(50):39012~39017
  • 5Shen W P, Proost P, Li B Q, et al. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Biochem Biophys Res Commun, 2000, 272:276~283
  • 6Le Y Y, Gong W H, Li B Q, et al. Utilization of two seventransmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activatio n. J Immunol, 1999, 163:6777
  • 7Su S B, Gao J L, Gong W H, et al. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-proteincoupled formyl peptide receptors. J Immunol, 1999, 162:5924~5930
  • 8Le Y Y, Yazawa H, Gong W H, et al. Cutting edge: the neurotoxic prion peptide fragment PrP106~126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J Immunol, 2001, 166:1448~1451
  • 9Lavigne M C, Murphy P M, Leto T L, et al. The Nformylpeptide receptor (FPR) and a second Gi-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils. Cell Immunol, 2002,218:7~12
  • 10Le Y Y, Wetzel M A, Shen W P, et al. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors.Clin Immunol, 2001, 99(3): 365~372

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部